In May 2025, Pelion S.A. and CEPD N.V. acquired a 9.68% stake in DocMorris AG, a leading company in the online pharmacy, marketplace, and professional healthcare sectors, with operations in countries including Switzerland, Germany, Spain, Portugal, and France. Currently, CEPD N.V. holds a 15.01% stake in DocMorris AG.
In a statement, DocMorris welcomed Pelion’s decision to invest in the company, expressing confidence in the potential of this new investor, who brings extensive experience in the pharmaceutical industry.
The Swiss-based DocMorris AG is a leading company in the fields of online pharmacies, marketplaces, and professional healthcare in Germany and other European countries. Deliveries are primarily handled from a highly automated logistics center in Heerlen, the Netherlands, which has a capacity of over 27 million parcels per year. In Spain and France, the company operates a leading marketplace for health and personal care products. Through its business model, DocMorris offers a wide range of products and services to its patients, customers, and partners. In doing so, DocMorris pursues its vision of creating a digital health ecosystem where everyone can manage their health with a single click. The company employs approximately 1,600 people across Germany, the Netherlands, Spain, France, Portugal, and Switzerland. In 2024, it had over 10 million active customers, and its sales revenue reached 1,085 million CHF.
“This investment is a natural consequence of our deliberate approach to building the healthcare of the future, in which online pharmacies play a vital role,” says Jacek Szwajcowski, CEO of Pelion S.A. “We have a deep understanding of the needs of patients, who expect fast service and excellent quality. We provide them not only with a broad product portfolio but also with access to consultations with pharmacists and doctors, as well as educational resources and diagnostic services. This is the foundation of HealthHub—our patient-friendly, comprehensive healthcare service.”